Related Experiment Videos
Abdominal aortic aneurysmectomy in octogenarian patients
1Department of Cardio-Vascular Surgery, University Hospital Rangueil, Toulouse, France.
The Journal of Cardiovascular Surgery
|January 1, 1990
Summary
Octogenarian patients undergoing abdominal aortic aneurysm (AAA) repair face high mortality, especially in emergencies. Elective surgery for asymptomatic AAA offers improved outcomes, with physiological age guiding patient selection.
Area of Science:
- Vascular Surgery
- Geriatric Medicine
- Aortic Aneurysm Research
Background:
- Octogenarian patients frequently present with abdominal aortic aneurysms (AAA), often complicated by comorbidities like renal, pulmonary, and cardiac disease.
- Surgical repair of AAA in this age group presents unique challenges due to increased physiological stress.
Purpose of the Study:
- To evaluate the outcomes of emergency versus elective surgical repair of abdominal aortic aneurysms (AAA) in patients aged 80 years and older.
- To determine the impact of comorbidities and surgical approach on in-hospital mortality in octogenarian AAA patients.
Main Methods:
- Retrospective analysis of 56 patients aged 80+ undergoing AAA repair.
- Classification of patients into emergency (intra-peritoneal and retro-peritoneal rupture) and elective surgery groups.
- Comparison of in-hospital mortality rates across different surgical groups and with historical data.
Main Results:
- Overall in-hospital mortality was 28.5%, significantly higher in emergency cases (71% for Group I, 45% for Group II) compared to elective cases (6.9%).
- Elective repair mortality (6.9%) exceeded the institutional rate for all ages (4.3%) for asymptomatic AAA.
- Post-successful repair, life expectancy approached that of the age-matched general population.
Conclusions:
- While age alone is not a contraindication, physiological status is crucial for selecting octogenarians for AAA repair.
- Preventive measures, including elective surgery for asymptomatic AAA (≥6 cm diameter), can improve outcomes.
- Contraindications include severe heart failure, advanced pulmonary, or neoplastic disease.